Immunome IMNM Net Interest Income
Net Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Immunome in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunome's net interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunome's net interest income?
- Immunome (IMNM) reported net interest income of $5.49M in Q1 2026.
- How has Immunome's net interest income changed year-over-year?
- Immunome's net interest income increased by 83.3% year-over-year, from $3M to $5.49M.
- What is the long-term trend for Immunome's net interest income?
- Over 4 years (2021 to 2025), Immunome's net interest income has grown at a 485.1% compound annual growth rate (CAGR), from -$10K to $11.72M.
- What does net interest income mean?
- This is the difference between the interest income generated from interest-bearing assets and the interest expense paid on liabilities. It serves as a primary indicator of a company's ability to manage its treasury operations and capital structure effectively. For non-financial firms, this metric highlights the net return on cash reserves and the cost of debt financing.